Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC009145 | Panoply™ Human MANF Knockdown Stable Cell Line | Inquiry |
| CSC-SC009145 | Panoply™ Human MANF Over-expressing Stable Cell Line | Inquiry |
| CSC-RT1170 | Human MANF Knockout Cell Line-HEK293T | Inquiry |
| CLOE-0145 | Human MANF(Fc) HEK293 Cell Lysate | Inquiry |
| CLOE-0910 | Human MANF(His) HEK293 Cell Lysate | Inquiry |
| CLKO-0672 | MANF KO Cell Lysate-HEK293T | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD09601Z | Human MANF adenoviral particles | Inquiry |
| LV17709L | human MANF (NM_006010) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH337407 | shRNA set against Mouse MANF (NM_029103.3) | Inquiry |
| SHH337403 | shRNA set against Human MANF (NM_006010.4) | Inquiry |
| SHH337411 | shRNA set against Rat MANF (NM_001108183.1) | Inquiry |
| SHW010405 | shRNA set against Danio rerio MANF (NM_001076629) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| RP00218 | Recombinant Human MANF (C-6His) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDFL007331 | Mouse Manf cDNA Clone(NM_029103.3) | Inquiry |
| CDFR007828 | Rat Manf cDNA Clone(NM_001108183.1) | Inquiry |
| MiUTR1M-01690 | MANF miRNA 3'UTR clone | Inquiry |
| MiUTR3H-04500 | MANF miRNA 3'UTR clone | Inquiry |
| SKO1037 | MANF Validated sgRNA vector | Inquiry |
| CDCB160418 | Human MANF ORF clone (NM_006010.3) | Inquiry |
| CDCB171880 | Danio rerio MANF ORF Clone (NM_001076629) | Inquiry |
| CDCB192740 | Rabbit MANF ORF clone (XM_008260718.1) | Inquiry |
| CDCH388555 | Human MANF ORF clone(NM_006010.4) | Inquiry |
| CDCL185245 | Mouse MANF ORF clone(NM_029103.3) | Inquiry |
| CDCR374867 | Rat Manf ORF Clone(NM_001108183.1) | Inquiry |
| CDCS418975 | Human MANF ORF Clone (BC007282) | Inquiry |
| CDCS418976 | Human MANF ORF Clone (BC113588) | Inquiry |
The mesencephalic astrocyte-derived ed neurotrophic factor (MANF) is a medium in which Petrova is equal to the first mid-brain type I astrocyte subcultured in vitro in 2003. A neurotrophic factor isolated to promote survival of dopaminergic neurons in vitro. It is also known as ARMET (arginine rich, mutated in early stage of tumurs) or ARP (arginine-rich protein). Another neurotrophic factor, the conserved dopamine neuro tro phic facto (CDNF), is a homologue of MANF. The homology of the two is >59%. A family of proteins that are conserved sequences of cysteine residues.
Physiological function of MANF
Studies have shown that MANF co-locates with endoplasmic reticulum and golgi membrane proteins. Brefeldin A(BFA) is used to block the protein transport between the endoplasmic reticulum and golgi, resulting in the increase of such proteins in the endoplasmic reticulum and the decrease of the amount in the culture medium. Degeneration of dopamine neuron axons, decrease of dopamine level and larvae death were observed in flies with the deletion of MANF gene, which supports that ANF is a dopamine neuron nutrient factor.
The endoplasmic reticulum is an important organelle of eukaryotic cells and is closely related to the metabolic processes of various membrane proteins, secreted proteins, phospholipids, and cholesterol. There is increasing evidence that MANF is an endoplasmic reticulum response protein, and high expression of MANF enhances cell tolerance to sugar-free status and other endoplasmic reticulum stress inducers. in vitro RNAi or in vivo knockdown of the ANF gene can cause death in cells or organisms under stress in the endoplasmic reticulum. Therefore, up-regulation of MANF may be an activation of an endogenous neuroprotective mechanism in cells under endoplasmic stress. Studies have shown that endoplasmic reticulum stress is up-regulated by the endoplasmic reticulum stress response element II. MANF may participate in unfolded protein response and improve cellular physiological state by degrading misfolded proteins, treating unfolded proteins, and regulating endoplasmic reticulum receptor activity.

Figure 1. Manf is essential for neurite extension and neuronal migration in the developing cortex. (Kuanyin, et al. 2017)
MANF and Parkinson's Disease
Studies have shown that deletion of the MANF/CDNF gene in glial cells leads to a series of pathological reactions caused by dopamine neuron loss and dopamine deficiency in animals. In the rat Parkinson's model induced by 6-hydoxy dopamine (6-OHDA), injection of M ANF/CDNF through the striatum not only protects midbrain dopamine neurons but also striatal dopaminergic nerve fibers. Moreover, it can strengthen the function of surviving neurons, repair the damaged nigrostria-striatum dopamine system, and reduce the dyskinesia in Parkinson's rats, which has the dual potential effects of prevention and treatment.
MANF and Cerebral Ischemic Injury
Neuroprotection is one of the effective methods for treating ischemic cerebrovascular. M ANF is not only found in midbrain dopamine neurons, but also abundantly expressed in the cerebral cortex and hippocampus. Cerebral ischemia causes changes in MANF expression in the hippocampus and the brain cortex. Transient or permanent cerebral ischemia can cause abnormal protein accumulation in the endoplasmic reticulum, endoplasmic reticulum stress, activate unfolded protein response, up-regulate the expression of MANF/CDNF in neurons, and enhance its immunological activity. It can reduce excessive apoptosis and necrosis of neurons in the ischemic area. MANF pretreatment can reduce the volume of infarcts in cerebral ischemia rats. It is beneficial to the recovery of behavioral function, which may be related to the reduction of glial cells in reactive hyperplasia in ischemic foci. This hypothesis is consistent with M ANF inhibition of proliferation of cultured cells in vitro.
References: